Similarly, C18.1, C18.2, and C18.3 also showed differences in Cyp4v3−/− mice compared to BCD patients [5, 34], suggesting Cyp4v3 may play a different role in mice from that of CYP4V2 in humans. This evidence concerns the gene CYP4V2 and Bietti crystalline dystrophy.